ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 24 filers reported holding ACASTI PHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 473 | +128.5% | 0.00% | – |
| Q4 2020 | $0 | – | 207 | +146.4% | 0.00% | – |
| Q3 2019 | $0 | – | 84 | +25.4% | 0.00% | – |
| Q1 2019 | $0 | – | 67 | +103.0% | 0.00% | – |
| Q4 2018 | $0 | – | 33 | -67.0% | 0.00% | – |
| Q2 2018 | $0 | – | 100 | +112.8% | 0.00% | – |
| Q1 2018 | $0 | – | 47 | +571.4% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | -92.8% | 0.00% | – |
| Q3 2017 | $0 | – | 97 | -50.3% | 0.00% | – |
| Q2 2017 | $0 | – | 195 | +509.4% | 0.00% | – |
| Q1 2017 | $0 | – | 32 | -88.1% | 0.00% | – |
| Q4 2016 | $0 | – | 268 | +972.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 25 | -96.1% | 0.00% | – |
| Q2 2016 | $1,000 | – | 634 | +228.5% | 0.00% | – |
| Q1 2016 | $0 | – | 193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 236,559 | $594,000 | 0.04% |
| INTACT INVESTMENT MANAGEMENT INC. | 89,490 | $287,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 210,484 | $537,000 | 0.00% |
| DEUTSCHE BANK AG\ | 215 | $0 | 0.00% |
| Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |
| CITIGROUP INC | 30 | $0 | 0.00% |
| MORGAN STANLEY | 18 | $0 | 0.00% |
| Renaissance Technologies | 20,900 | $53,000 | 0.00% |
| ROYAL BANK OF CANADA | 588 | $1,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 400 | $1,000 | 0.00% |